Process Modelling, Scale-Up and Characterization of Acetaminophen Spray Dried Milk Powder as Novel Pediatric Dosage Form

• Published in: Pharmaceutical research 2022-11, Vol.39 (11), p.2885-2903
• Main Authors: Shah, Harsh S., Syamala, Urmilasri, Chaudhari, Khushbu, Savjani, Jignasa, Butani, Shital
• Format: Article
• Language: English
• Subjects: Acetaminophen; Analgesics; Biochemistry; Biomedical and Life Sciences; Biomedical Engineering and Bioengineering; Biomedicine; Children; Dosage; Dosage and administration; Drug dosages; Drug therapy; Drying; Emerging Leaders in Pharmaceutical and Biomedical Sciences; Health aspects; Light microscopy; Medical Law; Muscles; Original Research Article; Patient compliance; Patients; Pediatric pharmacology; Pediatrics; Pharmacology/Toxicology; Pharmacy; Polarized light
• ISSN: 0724-8741; 1573-904X
• DOI: 10.1007/s11095-022-03354-3

Purpose Successful drug therapy in children is contingent upon hassle-free administration of pediatric dosage forms. Pediatric patients suffer from difficulty in swallowing due to weak esophagus muscles in their early age. Considering this challenge liquid formulations are preferred over solid dosage form among pediatric patients to avoid the possibility of choking which can be a serious life-threatening condition in children. The main aim of the present research work was to develop a reconstitutable amorphous acetaminophen spray-dried milk powder (ASDM) as novel pediatric formulation. Methods ASDM was prepared by spray drying process and the spray drying process was optimized using Box-Behnken design to study the effect of spray drying process parameters at X 1 [inlet temperature], X 2 [aspiration rate] and X 3 [feed rate] to Y 1 [% yield], Y 2 [angle of repose], Y 3 [Hausner’s Ratio] and Y 4 [Carr’s Index] as dependent variables of ASDM. In addition, each batch was characterized for particle size by polarized light microscopy and drug entrapment. Results Predicted parameters from optimized spray drying process model were successfully employed to manufacture a scale up cum validation batch of ASDM, which showed notably improved yield and desirable flow properties. The scale-up validation batch was further characterized using thermal analysis, diffraction studies, spectroscopic analysis, dispersion studies, stability APAP in dispersion formulation and formulation stability studies to confirm the physico-chemical stability of ASDM. Conclusions Thus, ASDM for oral use can serve as a promising pediatric formulation and the developed prototype formulation can be further extended to future newly discovered drugs with similar characteristics.